Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYR-PB21 vs bupivacaine for postoperative analgesia after arthroscopic rotator cuff repair
ChiCTR2400079849Phase 2Recruiting
- Sponsor
- Xijing Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HYR-PB21 in postoperative pain (3 arms), sponsored by Xijing Hospital. Primary endpoint: NRS AUC0-72h for pain intensity. Started Jan 2024; status: recruiting.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400079849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079849.